Atypical (RIO) protein kinases from Haemonchus contortus - Promise as new targets for nematocidal drugs

Biotechnology Advances

Volumn 29, Issue 3, 2011, Pages 338-350

  Campbell, Bronwyn E ^a   Boag, Peter R ^b   Hofmann, Andreas ^c   Cantacessi, Cinzia ^a   Wang, Conan K ^c   Taylor, Paul ^d   Hu, Min ^a   Sindhu, Zia ud Din ^a   Loukas, Alex ^e   Sternberg, Paul W ^f   Gasser, Robin B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e JAMES COOK UNIVERSITY   (Australia)

^f CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Drug targets; Haemonchus contortus; Inferred function; Parasite; Relationships; RIO kinases; Structure

Indexed keywords

DRUG TARGETS; HAEMONCHUS CONTORTUS; INFERRED FUNCTION; PARASITE-; RELATIONSHIPS; RIO KINASE; STRUCTURE;

AGRICULTURE; GENES; MAMMALS;

ENZYMES;

ANTHELMINTIC AGENT; PROTEIN KINASE;

DATA SET; DRUG DEVELOPMENT; DRUG RESISTANCE; ENZYME ACTIVITY; EUKARYOTE; GENE EXPRESSION; NEMATODE; PARASITE; RUMINANT;

ANIMAL; ENZYMOLOGY; GENETICS; HAEMONCHUS; METABOLISM; REVIEW;

ANIMALS; ANTHELMINTICS; HAEMONCHUS; PROTEIN KINASES;

CAENORHABDITIS ELEGANS; EUKARYOTA; HAEMONCHUS CONTORTUS; NEMATODA;

EID: 79952684289     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.01.006     Document Type: Review

References (76)

1. Alekshun M.N., Levy S.B. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 1999, 7:410-413.
2. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
3. Angermayr M., Bandlow W. Rio1, an extraordinary novel protein kinase. FEBS Lett 2002, 524:31-36.
4. Angermayr M., Roidl A., Bandlow W. Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression. Mol Microbiol 2002, 44:309-324.
5. Aravind L., Anantharaman V., Balaji S., Babu M.M., Iyer L.M. The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 2005, 29:231-262.
6. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25:25-29.
7. Ashrafi K., Chang F.Y., Watts J.L., Fraser A.G., Kamath R.S., Ahringer J., et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 2003, 421:268-272.
8. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003, 371:199-204.
9. Balklava Z., Pant S., Fares H., Grant B.D. Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic. Nat Cell Biol 2007, 9:1066-1073.
10. Bateman A., Birney E., Durbin R., Eddy S.R., Howe K.L., Sonnhammer E.L. The Pfam protein families database. Nucleic Acids Res 2000, 28:263-266.
11. Bott N.J., Campbell B.E., Beveridge I., Chilton N.B., Rees D., Hunt P.W., et al. A combined microscopic-molecular method for the diagnosis of strongylid infections in sheep. Int J Parasitol 2009, 39:1277-1287.
12. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 1981, 50:349-383.
13. Bryson K., McGuffin L.J., Marsden R.L., Ward J.J., Sodhi J.S., Jones D.T. Protein structure prediction servers at University College London. Nucleic Acids Res 2005, 33:W36-W38.
14. Bult C.J., Epping J.T., Kadin J.A., Richardson J.E., Blake J.A. The mouse genome database (MGD): mouse biology and model systems. Nucleic Acids Res 2008, 36:D724-D728.
15. Caffrey C.R., Rohwer A., Oellien F., Marhofer R.J., Braschi S., Oliveira G., et al. A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One 2009, 4:e4413.
16. Cantacessi C., Mitreva M., Jex A.R., Young N.D., Campbell B.E., Hall R.S., et al. Massively parallel sequencing and analysis of the Necator americanus transcriptome. PLoS Negl Trop Dis 2010, 4:e684.
17. Cavasotto C.N., Phatak S.S. Homology modeling in drug discovery: current trends and applications. Drug Discov Today 2009, 14:676-683.
18. Ceron J., Rual J.F., Chandra A., Dupuy D., Vidal M., van den Heuvel S. Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity. BMC Dev Biol 2007, 7:30.
19. Chang A., Scheer M., Grote A., Schomburg I., Schomburg D. BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009. Nucleic Acids Res 2009, 37:D588-D592.
20. Cherry J.M., Ball C., Weng S., Juvic G., Schmidt R., Adler C., et al. Genetic and physical maps of Saccharomyces cerevisiae. Nature 1997, 387:67-73.
21. Cho Y.Y., Yao K., Kim H.G., Kang B.S., Zheng D., Bode A.M., et al. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res 2007, 67:8104-8112.
22. Conder G.A., Johnson S.S. Viability of infective larvae of Haemonchus contortus, Ostertagia ostertagi, and Trichostrongylus colubriformis following exsheathment by various techniques. J Parasitol 1998, 82:100e2.
23. Cooke R.G., Fletcher R.A.H. Isoflavonoids III - constituents of Cotoneaster species. Aust J Chem 1974, 27:1377-1379.
24. Dayong S., Wang Y., Zhou Y.H., Guo Y., Wang J., Zhou H., et al. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 2009, 37:629-634.
25. Deininger M.W., Vieira S., Mendiola R., Schultheis B., Goldman J.M., Melo J.V. BCR-ABL Tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Cancer Res 2000, 60:2049-2055.
26. DeLano W.L. The PyMOLmolecular graphics system http://www.pymol.org.
27. Doyle M.A., Gasser R.B., Woodcroft B.J., Hall R.S., Ralph S.A. Drug target prediction and prioritization: using orthology to predict essentiality in parasite genomes. BMC Genomics 2010, 11:222.
28. Eddy S.R. A new generation of homology search tools based on probabilistic inference. Genome Inform 2009, 23:205-211.
29. Ferreira C.V., Gusto G.Z., Sousa A.C., Queiroz K.C., Zambuzzi W.F., Aoyama H., et al. Natural compounds as a source of protein phosphatase inhibitors; application to the rational design of small-molecule derivatives. Biochemie 2006, 88:1859-1873.
30. Fire A.Z. Gene silencing by double-stranded RNA. Cell Death Differ 2007, 14:1998-2012.
31. Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J.A. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000, 408:325-330.
32. Gasser R.B., Hu M., Chilton N.B., Campbell B.E., Jex A.R., Otranto D., et al. Single-strand conformation polymorphism (SSCP) for the analysis of genetic variation. Nat Protoc 2006, 1:3121-3128.
33. Gasteiger J. Chemoinformatics: a new field with a long tradition. Anal Bioanal Chem 2006, 384:57-64.
34. Geerlings T.H., Faber A.W., Bister M.D., Vos J.C., Raué H.A. Rio2p, an evolutionarily conserved, low abundant protein kinase essential for processing of 20S Pre-rRNA in Saccharomyces cerevisiae. J Biol Chem 2003, 278:22537-22545.
35. Gonczy P., Cassin E., Hannak E., Kirkham M., Pichler S.C., Flohrs K., et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 2000, 408:331-336.
36. Granneman S., Petfalski E., Swiatkowska A., Tollervey D. Cracking pre-40S ribosomal subunit structure by systematic analyses of RNA-protein cross-linking. EMBO J 2010, 29:2026-2036.
37. Hammami R., Fliss I. Current trends in antimicrobial agent research: chemo- and bioinformatics approaches. Drug Discov Today 2010, 15:540-546.
38. Hanks S.K., Hunter T. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1995, 9:576-596.
39. Hanks S.K., Quinn A.M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988, 241:42-52.
40. Hofmann A., Wlodawer A. PCSB - a programme collection for structural biology and biophysical chemistry. Bioinformatics 2002, 18:209-210.
41. Holliday J.D., Hu C.Y., Willett P. Grouping of coefficients for the calculation of inter-molecular similarity and dissimilarity using 2D fragment bit-strings. Comb Chem High Throughput Screen 2002, 5:155-166.
42. Hopkins A.L., Groom C.R. The druggable genome. Nat Rev Drug Discov 2002, 1:727-730.
43. Hu M., LaRonde-LeBlanc N., Sternberg P.W., Gasser R.B. Tv-RIO1 - an atypical protein kinase from the parasitic nematode Trichostrongylus vitrinus. Parasit Vectors 2008, 1:34.
44. Huang X. A contig assembly program based on sensitive detection of fragment overlaps. Genomics 1992, 14:18-25.
45. Hunter S., Apweiler R., Attwood T.K., Bairoch A., Bateman A., Binns D., et al. InterPro: the integrative protein signature database. Nucleic Acids Res 2009, 37:D211-D215.
46. Hur W., Velentza A., Kim S., Flatauer L., Jiang X., Valente D., et al. Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase. Bioorg Med Chem Lett 2008, 18:5916-5919.
47. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and location of errors in these models. Acta Crystallogr A 1991, 47:110-119.
48. Kimmelman A.C., Hezel A.F., Aguirre A.J., Zheng H., Paik J.H., Ying H., et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 2008, 105:19372-19377.
49. Krasky A., Rohwer A., Schroeder J., Selzer P.M. A combined bioinformatics and chemoinformatics approach for the development of new antiparasitic drugs. Genomics 2007, 89:36-43.
50. LaRonde-LeBlanc N., Wlodawer A. A family portrait of the RIO kinases. J Biol Chem 2005, 280:37297-37300.
51. LaRonde-LeBlanc N., Wlodawer A. The Rio kinases: an atypical protein kinase family required for ribosome biogenesis and cell cycle progression. Biochim Biophys Acta 2005, 1754:14-24.
52. Laskowski R., MacArthur M., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993, 26:283-291.
53. Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997, 23:3-25.
54. Manning G. Genomic overview of protein kinases. WormBook 2005, 1-19.
55. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
56. National Toxicology Program NTP Toxicology and Carcinogenesis Studies of EMODIN (CAS NO. 518-82-1). Feed Studies in F344/N Rats and B6C3F1 Mice. Natl Toxicol Program Tech Rep Ser 2001, 493:1-278.
57. Nikolaou S., Hartman D., Presidente P.J., Newton S.E., Gasser R.B. HcSTK, a Caenorhabditis elegans PAR-1 homologue from the parasitic nematode, Haemonchus contortus. Int J Parasitol 2002, 32:749-758.
58. Nöthlings U., Murphy S.P., Wilkens L.R., Henderson B.E., Kolone L.N. Flavonols and pancreatic cancer risk. Am J Epidemiol 2007, 166:924-931.
59. Park J.S., Rho H.S., Kim D.H., Chang I.S. Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity. J Agric Food Chem 2006, 54:2951-2956.
60. Peng H., Huang N., Qi J., Xie P., Xu C., Wang J., et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett 2003, 13:3693-3699.
61. Robertson J.G. Mechanistic basis of enzyme-targeted drugs. Biochemistry 2005, 44:5561-5571.
62. Ronquist F., Huelsenbeck J.P. MRBAYES 3: bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19:1572e4.
63. Rual J.F., Ceron J., Koreth J., Hao T., Nicot A.S., Hirozane-Kishikawa T., et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 2004, 14:2161-2168.
64. Sali A., Blundell T. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234:779-815.
65. Schäfer T., Strauss D., Petfalski E., Tollervey D., Hurt E. The path from nucleolar 90S to cytoplasmic 40S pre-ribosomes. EMBO J 2003, 22:1370-1380.
66. Simmer F., Moorman C., van der Linden A.M., Kuijk E., van den Berghe P.V.E., Kamath F.S., et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol 2003, 1:77-84.
67. Simpson K.J., Selfors L.M., Bui J., Reynolds A., Leake D., Khvorova A., Brugge J.S. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol. 2008, 10:1027-1038.
68. Sonnichsen B., Koski L.B., Walsh A., Marschall P., Neumann B., Brehm M., et al. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 2005, 434:462-469.
69. Stanke M., Morgenstern B. AUGUSTUS: a web server for gene prediction in eukaryotes that allows user-defined constraints. Nucleic Acids Res 2005, 33:W465-W467.
70. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
71. Tweedie S., Ashburner M., Falls K., Leyland P., McQuilton P., Marygold S., et al. FlyBase Consortium. FlyBase: enhancing Drosophila Gene Ontology annotations. Nucleic Acids Res 2009, 37:D555-D559.
72. Vangrevelinghe E., Zimmermann K., Schoepfer J., Portmann R., Fabbro D., Furet P. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J Med Chem 2003, 46:2656-2662.
73. Vanrobays E., Gleizes P., Bousquet-Antonelli C., Noaillac-Depeyre J., Caizergues-Ferrer M., Gélugne J. Processing of 20S pre-rRNA to 18S ribosomal RNA in yeast requires Rrp10p, an essential non-ribosomal cytoplasmic protein. EMBO J 2001, 20:4204-4213.
74. Vanrobays R., Gelugne J., Gleizes P., Caizergues-Ferrer M. Later cytoplasmic maturation of the small ribosomal subunit required RIO proteins in Saccharomyces cerevisiae. Mol Cell Biol 2003, 23:2083-2095.
75. Villoutreix B.O., Renault N., Lagorce D., Sperandio O., Montes M., Miteva M.A. Free resources to assist structure-based virtual ligand screening experiments. Curr Protein Pept Sci 2007, 8:381-411.
76. Wu S.Y., McNae I., Kontopidis G., McClue S.J., McInnes C., Stewart K.J., et al. Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure 2003, 11:399-410.